National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

retaspimycin hydrochloride
The hydrochloride salt of a small-molecule inhibitor of heat shock protein 90 (HSP90) with antiproliferative and antineoplastic activities. Retaspimycin binds to and inhibits the cytosolic chaperone functions of HSP90, which maintains the stability and functional shape of many oncogenic signaling proteins and may be overexpressed or overactive in tumor cells. Retaspimycin-mediated inhibition of HSP90 promotes the proteasomal degradation of oncogenic signaling proteins in susceptible tumor cell populations, which may result in the induction of apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:IPI-504



Previous:Rencarex, Renova, Resectisol, Respbid, resveratrol
Next:Retin-A, Retin-A MICRO, retinoid analogue NRX 195183, retinyl acetate, retrovector encoding mutant anti-cyclin G1

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov